Efficacy of Anakinra in Refractory Adult-Onset Still's Disease
暂无分享,去创建一个
M. González-Gay | J. Llorca | P. Carreira | S. Castañeda | J. Bernal | M. V. Hernández | M. Velloso-Feijoó | A. Olivé | C. Ordóñez | R. Blanco | I. Jiménez-Moleón | L. Riancho-Zarrabeitia | J. Loricera | T. Pina | M. Gonzalez-vela | J. Narváez | M. Moreno | V. Ortiz-Santamaria | V. Calvo-Río | F. Ortiz-Sanjuan | J. R. de Dios | J. Fiter | V. Calvo‐Río | O. Maíz-Alonso | J. Blanco-madrigal | W. Sifuentes-Giraldo | N. Palmou-Fontana | C. Gómez-Arango | E. Galíndez-Agirregoikoa | A. Riveros | J. del Blanco-Barnusell | M. D. L. Riscos | María J. Rodriguez-Valls | M. Gonzalez-Vela | M. V. Hernandez | María V. Hernandez
[1] C. Campochiaro,et al. Efficacy and safety of biological agents in adult-onset Still’s disease , 2015, Scandinavian journal of rheumatology.
[2] Dongsheng Hong,et al. Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety , 2014, Drug design, development and therapy.
[3] S. Castañeda,et al. Efficacy of Tocilizumab in Conventional Treatment–Refractory Adult‐Onset Still's Disease: Multicenter Retrospective Open‐Label Study of Thirty‐Four Patients , 2014, Arthritis & rheumatology.
[4] Z. Amoura,et al. Anakinra in Adult‐Onset Still's Disease: Long‐Term Treatment in Patients Resistant to Conventional Therapy , 2013, Arthritis care & research.
[5] Sung Bin Cho,et al. Detection of the inflammatory process in a Behçet's disease-like mouse model using 18F-fluorodeoxyglucose positron emission tomography. , 2013, Clinical and experimental rheumatology.
[6] H. Kautiainen,et al. Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still’s Disease. An Open, Randomized, Multicenter Study , 2012, The Journal of Rheumatology.
[7] B. Fautrel,et al. Anti-Interleukin-1 Agents in Adult Onset Still's Disease , 2012, International journal of inflammation.
[8] A. Tzioufas,et al. Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study , 2011, Arthritis research & therapy.
[9] J. Nolla,et al. Adult onset Still's disease: review of 41 cases. , 2011, Clinical and experimental rheumatology.
[10] Paul Landais,et al. Extended Report , 2022 .
[11] Andreas Krause,et al. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still’s disease , 2010, Annals of the rheumatic diseases.
[12] L. Kanz,et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. , 2007, Seminars in arthritis and rheumatism.
[13] J. Sibilia,et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France , 2007, Annals of the rheumatic diseases.
[14] G. Kalliolias,et al. Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial , 2007, Annals of the rheumatic diseases.
[15] C. Dinarello,et al. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. , 2005, Arthritis and rheumatism.
[16] L. Moreland,et al. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate , 2004, Annals of the rheumatic diseases.
[17] T. Mimori,et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. , 2001, Rheumatology.
[18] M. Kikuchi,et al. Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease. , 1998, The Journal of rheumatology.
[19] M. Akizuki,et al. Preliminary criteria for classification of adult Still's disease. , 1992, The Journal of rheumatology.
[20] J. Esdaile,et al. Adult Still's Disease: Manifestations, Disease Course, and Outcome in 62 Patients , 1991, Medicine.
[21] P. Voulgari,et al. Adult-onset Still's disease: clinical, serological and therapeutic considerations. , 2013, Clinical and experimental rheumatology.